Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001478297-13-000001
Filing Date
2013-02-01
Accepted
2013-01-31 19:21:26
Documents
1
Effectiveness Date
2013-02-01
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11958
  Complete submission text file 0001478297-13-000001.txt   13272
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-191198 | Film No.: 13564270
SIC: 2835 In Vitro & In Vivo Diagnostic Substances